Transcriptional Targeting Killing Effect of Human Giant Cell Lung Cancer Cell Lines with CD+TK/GCV+5-FC Driven by KDR Promotor

Guowei CHE,Lunxu LIU,Qinghua ZHOU,Yanping WANG,Wen ZHU,Junke FU,Jiangtao SUN,Yun WANG,Xiaohe CHEN
2009-01-01
Chinese Journal of Lung Cancer
Abstract:Background and objective To explore the di erent killing e ect to human giant cell lung cancer cell lines L9981 and L9980 with CD+TK/GCV+5-FC driven by KDR promotor. Methods KDRp was cloned and an expression vector containing CD-TK gene under the KDR promotor (pcDNA3-KDRp-CdglyTK) was constructed by molecular biological methods, and then was transfected into human giant cell lung cancer cell line L9981 and L9980 , and human hepatic cancer cell line HepG2 .the cytotoxicity to these transgenic cells under treatment with GCV and /or 5-FC were measured by MTT assays. In addition ,the tumor suppression effects of different treatments were investigated in nude mice bearing inoculative lung cancer. Results KDRp was successfully cloned and pcDNA3-KDRp-CdglyTK was constructed .CD and TK gene was expressed in L9981 and L9980 cells after pcDNA3-KDRp-CdglyTK transfection, but not in HepG2 cells. The killing e ect of the two produrgs used in combination was much stronger than that of exclusive use of GCV or 5-FC(P<0.05), There was no cytotoxic e ect on the cells transfected with pcDNA3-KDRp-CDglyTK to prodrugs (GCVand/or5-FC) in KDR protein negative cells(p>0.05).. In vivo experiment revealed that the tumorigenesis of L9981 and NL9980 cell transfected CDglyTK are inhibited with combined intraperitoneal injection GCV and 5-FC in nude mouse. Conclusion Tumor targeted expression of CdglyTK gene under the control of KDR promotor represents a novel strategy for safe and effective gene therapy of cancer and might have wide application in the future.
What problem does this paper attempt to address?